Mutual Advisors LLC Decreases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Mutual Advisors LLC lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,600 shares of the financial services provider’s stock after selling 108 shares during the period. Mutual Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,359,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Jane Street Group LLC purchased a new position in iShares Biotechnology ETF in the first quarter valued at $14,386,000. Cetera Investment Advisers boosted its position in shares of iShares Biotechnology ETF by 689.4% during the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after acquiring an additional 79,541 shares in the last quarter. State of Michigan Retirement System increased its holdings in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after acquiring an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $9,180,000. Finally, Sanctuary Advisors LLC purchased a new stake in iShares Biotechnology ETF during the second quarter worth approximately $8,118,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.8 %

Shares of iShares Biotechnology ETF stock opened at $142.78 on Friday. iShares Biotechnology ETF has a 52 week low of $113.56 and a 52 week high of $150.57. The firm’s 50 day moving average is $145.02 and its two-hundred day moving average is $140.37.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.